vs
Side-by-side financial comparison of READING INTERNATIONAL INC (RDI) and Vanda Pharmaceuticals Inc. (VNDA). Click either name above to swap in a different company.
Vanda Pharmaceuticals Inc. is the larger business by last-quarter revenue ($57.2M vs $50.3M, roughly 1.1× READING INTERNATIONAL INC). READING INTERNATIONAL INC runs the higher net margin — -5.1% vs -246.8%, a 241.7% gap on every dollar of revenue. On growth, Vanda Pharmaceuticals Inc. posted the faster year-over-year revenue change (7.6% vs -14.2%). READING INTERNATIONAL INC produced more free cash flow last quarter ($4.1M vs $-29.5M). Over the past eight quarters, Vanda Pharmaceuticals Inc.'s revenue compounded faster (9.8% CAGR vs 5.6%).
The Reading Company was a Philadelphia-headquartered railroad that provided passenger and freight transport in eastern Pennsylvania and neighboring states from 1924 until its acquisition by Conrail in 1976.
Vanda Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for central nervous system disorders. Its key marketed products cover indications including sleep-wake cycle disturbances and schizophrenia, with core operations and primary sales markets concentrated in North America, catering to patient groups with significant unmet medical needs.
RDI vs VNDA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $50.3M | $57.2M |
| Net Profit | $-2.6M | $-141.2M |
| Gross Margin | — | — |
| Operating Margin | -1.9% | -70.5% |
| Net Margin | -5.1% | -246.8% |
| Revenue YoY | -14.2% | 7.6% |
| Net Profit YoY | -14.5% | -2774.3% |
| EPS (diluted) | $-0.11 | $-2.40 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $50.3M | $57.2M | ||
| Q3 25 | $52.2M | $56.3M | ||
| Q2 25 | $60.4M | $52.6M | ||
| Q1 25 | $40.2M | $50.0M | ||
| Q4 24 | $58.6M | $53.2M | ||
| Q3 24 | $60.1M | $47.7M | ||
| Q2 24 | $46.8M | $50.5M | ||
| Q1 24 | $45.1M | $47.5M |
| Q4 25 | $-2.6M | $-141.2M | ||
| Q3 25 | $-4.2M | $-22.6M | ||
| Q2 25 | $-2.7M | $-27.2M | ||
| Q1 25 | $-4.8M | $-29.5M | ||
| Q4 24 | $-2.2M | $-4.9M | ||
| Q3 24 | $-7.0M | $-5.3M | ||
| Q2 24 | $-12.8M | $-4.5M | ||
| Q1 24 | $-13.2M | $-4.1M |
| Q4 25 | -1.9% | -70.5% | ||
| Q3 25 | -0.6% | -55.6% | ||
| Q2 25 | 4.8% | -73.2% | ||
| Q1 25 | -17.2% | -82.0% | ||
| Q4 24 | 2.6% | -19.3% | ||
| Q3 24 | -0.6% | -23.1% | ||
| Q2 24 | -16.4% | -20.1% | ||
| Q1 24 | -16.7% | -19.5% |
| Q4 25 | -5.1% | -246.8% | ||
| Q3 25 | -8.0% | -40.1% | ||
| Q2 25 | -4.4% | -51.7% | ||
| Q1 25 | -11.8% | -58.9% | ||
| Q4 24 | -3.8% | -9.2% | ||
| Q3 24 | -11.7% | -11.2% | ||
| Q2 24 | -27.4% | -9.0% | ||
| Q1 24 | -29.4% | -8.7% |
| Q4 25 | $-0.11 | $-2.40 | ||
| Q3 25 | $-0.18 | $-0.38 | ||
| Q2 25 | $-0.12 | $-0.46 | ||
| Q1 25 | $-0.21 | $-0.50 | ||
| Q4 24 | $-0.11 | $-0.09 | ||
| Q3 24 | $-0.31 | $-0.09 | ||
| Q2 24 | $-0.57 | $-0.08 | ||
| Q1 24 | $-0.59 | $-0.07 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $10.5M | $84.9M |
| Total DebtLower is stronger | $185.1M | — |
| Stockholders' EquityBook value | $-18.2M | $327.2M |
| Total Assets | $434.9M | $488.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.5M | $84.9M | ||
| Q3 25 | $8.1M | $70.0M | ||
| Q2 25 | $9.1M | $81.0M | ||
| Q1 25 | $5.9M | $111.8M | ||
| Q4 24 | $12.4M | $102.3M | ||
| Q3 24 | $10.1M | $100.5M | ||
| Q2 24 | $9.3M | $103.0M | ||
| Q1 24 | $7.5M | $125.2M |
| Q4 25 | $185.1M | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $202.7M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $-18.2M | $327.2M | ||
| Q3 25 | $-12.1M | $466.0M | ||
| Q2 25 | $-7.7M | $486.3M | ||
| Q1 25 | $-8.1M | $511.4M | ||
| Q4 24 | $-4.4M | $538.5M | ||
| Q3 24 | $1.6M | $541.2M | ||
| Q2 24 | $6.5M | $542.5M | ||
| Q1 24 | $18.0M | $544.0M |
| Q4 25 | $434.9M | $488.9M | ||
| Q3 25 | $435.2M | $601.1M | ||
| Q2 25 | $438.1M | $624.7M | ||
| Q1 25 | $441.0M | $631.9M | ||
| Q4 24 | $471.0M | $656.2M | ||
| Q3 24 | $495.7M | $645.1M | ||
| Q2 24 | $494.9M | $651.4M | ||
| Q1 24 | $494.9M | $652.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $4.3M | $-29.4M |
| Free Cash FlowOCF − Capex | $4.1M | $-29.5M |
| FCF MarginFCF / Revenue | 8.2% | -51.6% |
| Capex IntensityCapex / Revenue | 0.3% | 0.2% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-2.9M | $-110.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.3M | $-29.4M | ||
| Q3 25 | $295.0K | $-31.6M | ||
| Q2 25 | $1.6M | $-15.3M | ||
| Q1 25 | $-7.7M | $-33.1M | ||
| Q4 24 | $8.0M | $-1.8M | ||
| Q3 24 | $1.3M | $-14.6M | ||
| Q2 24 | $-10.4M | $-6.9M | ||
| Q1 24 | $-2.8M | $7.6M |
| Q4 25 | $4.1M | $-29.5M | ||
| Q3 25 | $-246.0K | $-31.8M | ||
| Q2 25 | $1.2M | $-15.6M | ||
| Q1 25 | $-8.0M | $-33.6M | ||
| Q4 24 | $7.0M | $-2.0M | ||
| Q3 24 | $-1.1M | $-14.7M | ||
| Q2 24 | $-10.6M | $-7.0M | ||
| Q1 24 | $-4.7M | $7.6M |
| Q4 25 | 8.2% | -51.6% | ||
| Q3 25 | -0.5% | -56.5% | ||
| Q2 25 | 1.9% | -29.6% | ||
| Q1 25 | -19.8% | -67.1% | ||
| Q4 24 | 12.0% | -3.8% | ||
| Q3 24 | -1.8% | -30.9% | ||
| Q2 24 | -22.7% | -13.9% | ||
| Q1 24 | -10.4% | 15.9% |
| Q4 25 | 0.3% | 0.2% | ||
| Q3 25 | 1.0% | 0.3% | ||
| Q2 25 | 0.6% | 0.6% | ||
| Q1 25 | 0.6% | 0.9% | ||
| Q4 24 | 1.7% | 0.4% | ||
| Q3 24 | 4.0% | 0.3% | ||
| Q2 24 | 0.5% | 0.2% | ||
| Q1 24 | 4.3% | 0.0% |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
RDI
| Cinema Exhibition Segment | $46.9M | 93% |
| Real Estate Revenue | $3.4M | 7% |
VNDA
| Fanapt | $33.2M | 58% |
| Hetlioz | $16.4M | 29% |
| PONVORY | $7.6M | 13% |
